ストックスクリーナーアプリを入手
0.0125
1.63%
0.0002
前日終値:
$0.0123
開ける：
$0.0121
24時間の取引高:
21,683
Relative Volume:
40.44
時価総額：
$N/A
収益：
-
当期純損益:
$-48.85M
株価収益率:
-0.00541
EPS:
-2.31
ネットキャッシュフロー:
$-46.25M
1週間 パフォーマンス:
+1.63%
1か月 パフォーマンス:
-61.54%
6か月 パフォーマンス:
-99.23%
1年 パフォーマンス:
-99.66%
1日の値動き範囲:
$0.0121
$0.0126
1週間の範囲:
$0.0121
$0.0126
52週間の値動き範囲:
$0.0101
$0.041
Vincerx Pharma Inc Stock (VINC) Company Profile
VINC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VINC
Vincerx Pharma Inc
|
0.0125 | 0 | 0 | -48.85M | -46.25M | -2.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-01-14 | 開始されました | H.C. Wainwright | Buy |
| 2021-12-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-11-01 | 開始されました | SVB Leerink | Outperform |
| 2021-09-13 | 開始されました | Laidlaw | Buy |
| 2021-08-25 | 開始されました | B. Riley Securities | Buy |
Vincerx Pharma Inc (VINC) 最新ニュース
Vincerx Pharma, Inc. (VINC) Stock forecasts - Yahoo
Analyzing Neoleukin Therapeutics (NASDAQ:NLTX) & Vincerx Pharma (NASDAQ:VINC) - Defense World
Vincerx Pharma, Inc. (VINC) stock price, news, quote and history - Yahoo
Vincerx Pharma, Inc.Common Stock (NQ: VINC - FinancialContent
Vincerx Pharma ends sales agreement, approves reverse stock split - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders - ACCESS Newswire
Vincerx Pharma (NASDAQ:VINC) vs. NovaBay Pharmaceuticals (NYSE:NBY) Financial Survey - Defense World
Vincerx Pharma, Inc. Announces Additional Adjournment of - GlobeNewswire
Vincerx Warns Stockholders: Delayed Dissolution Vote Threatens $0.07 Per Share DistributionAction Required - Stock Titan
Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders - The Manila Times
Vincerx announces potential distribution of $0.04-$0.08 per share By Investing.com - Investing.com South Africa
Vincerx announces potential distribution of $0.04-$0.08 per share - Investing.com
Vincerx Pharma, Inc. Urges Stockholders to Vote FOR - GlobeNewswire
Vincerx Pharma Stockholders Face Critical July 16 Vote: $0.08 Per Share at Stake in Dissolution Plan - Stock Titan
Vincerx Pharma enters at-the-market equity offering deal - MSN
Vincerx Pharma, Inc. Announces Adjournment of Special MeetingWill Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal - GlobeNewswire
Vincerx Pharma Stockholders Risk Losing All Distribution Value if Dissolution Vote Fails by July 16 - Stock Titan
At a crossroads, biotechs are passing on reverse mergers in 2025 - Endpoints News
TC BioPharm’s $100M Shelf Offering: A Beacon of Resilience in a Collapsing Biotech Landscape - AInvest
VINC Stock Price and Chart — OTC:VINC - TradingView
VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com UK
Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India
vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com UK
Vincerx prepares to wind down as final merger attempt collapses - Fierce Biotech
Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com
Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks
VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com
Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World
Vincerx Pharma Inc. (VINC) reports earnings - qz.com
Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewswire
Finance Watch: Sutro Halves Workforce, Cuts Lead ADC And CEO Moves On - insights.citeline.com
Vincerx Pharma Plunges After Scrapping Reverse Merger With Oqory And Vivaso - Nasdaq
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - Yahoo Finance
VINC stock touches 52-week low at $1.3 amid market challenges - Investing.com
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258 - GlobeNewswire
Vincerx Pharma, Inc. Announces 1-for-20 Reverse Stock Split Effective January 27, 2025 - Nasdaq
Palo Alto's Vincerx Pharma plans reverse stock split amid merger plans - The Business Journals
Vincerx Pharma, Inc. Announces Reverse Stock Split - GlobeNewswire
Vincerx Pharma ends sales agreement, approves reverse stock split By Investing.com - Investing.com UK
Investor law firms question biotech merger's 'fairness' - The Business Journals
Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc.VINC | FinancialContent - FinancialContent
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech
PRN_FinancialWrapper - FinancialContent
Vincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains Bullish - Stocktwits
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. - Yahoo Finance
Vincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug Trials - Stocktwits
Vincerx Pharma Reports Promising Cancer Drug Results, Explores Strategic Options Amid Cost Cuts - Stock Titan
Vincerx Pharma Inc (VINC) Quarterly 10-Q Report - qz.com
What Makes Vincerx Pharma (VINC) a New Buy Stock - Yahoo Finance
VINC Stock Touches 52-Week Low at $0.51 Amid Market Challenges - Investing.com
Vincerx Pharma Inc (VINC) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):